168 related articles for article (PubMed ID: 12692135)
1. P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.
Fomenkov A; Huang YP; Topaloglu O; Brechman A; Osada M; Fomenkova T; Yuriditsky E; Trink B; Sidransky D; Ratovitski E
J Biol Chem; 2003 Jun; 278(26):23906-14. PubMed ID: 12692135
[TBL] [Abstract][Full Text] [Related]
2. AEC-associated p63 mutations lead to alternative splicing/protein stabilization of p63 and modulation of Notch signaling.
Huang YP; Kim Y; Li Z; Fomenkov T; Fomenkov A; Ratovitski EA
Cell Cycle; 2005 Oct; 4(10):1440-7. PubMed ID: 16177572
[TBL] [Abstract][Full Text] [Related]
3. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L
Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of p63 mutations in a selected patient cohort affected with ankyloblepharon-ectodermal defects-cleft lip/palate syndrome (AEC).
Rinne T; Bolat E; Meijer R; Scheffer H; van Bokhoven H
Am J Med Genet A; 2009 Sep; 149A(9):1948-51. PubMed ID: 19676060
[TBL] [Abstract][Full Text] [Related]
5. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
Westfall MD; Mays DJ; Sniezek JC; Pietenpol JA
Mol Cell Biol; 2003 Apr; 23(7):2264-76. PubMed ID: 12640112
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.
Testoni B; Mantovani R
Nucleic Acids Res; 2006; 34(3):928-38. PubMed ID: 16473849
[TBL] [Abstract][Full Text] [Related]
7. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63.
McGrath JA; Duijf PH; Doetsch V; Irvine AD; de Waal R; Vanmolkot KR; Wessagowit V; Kelly A; Atherton DJ; Griffiths WA; Orlow SJ; van Haeringen A; Ausems MG; Yang A; McKeon F; Bamshad MA; Brunner HG; Hamel BC; van Bokhoven H
Hum Mol Genet; 2001 Feb; 10(3):221-9. PubMed ID: 11159940
[TBL] [Abstract][Full Text] [Related]
8. Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.
Chung J; Grant RI; Kaplan DR; Irwin MS
J Biol Chem; 2011 Nov; 286(47):40671-80. PubMed ID: 21965674
[TBL] [Abstract][Full Text] [Related]
9. A novel p63 sterile alpha motif (SAM) domain mutation in a Japanese patient with ankyloblepharon, ectodermal defects and cleft lip and palate (AEC) syndrome without ankyloblepharon.
Tsutsui K; Asai Y; Fujimoto A; Yamamoto M; Kubo M; Hatta N
Br J Dermatol; 2003 Aug; 149(2):395-9. PubMed ID: 12932250
[TBL] [Abstract][Full Text] [Related]
10. The Hay Wells syndrome-derived TAp63alphaQ540L mutant has impaired transcriptional and cell growth regulatory activity.
Lo Iacono M; Di Costanzo A; Calogero RA; Mansueto G; Saviozzi S; Crispi S; Pollice A; La Mantia G; Calabrò V
Cell Cycle; 2006 Jan; 5(1):78-87. PubMed ID: 16319531
[TBL] [Abstract][Full Text] [Related]
11. De novo missense mutation, S541Y, in the p63 gene underlying Rapp-Hodgkin ectodermal dysplasia syndrome.
Shotelersuk V; Janklat S; Siriwan P; Tongkobpetch S
Clin Exp Dermatol; 2005 May; 30(3):282-5. PubMed ID: 15807690
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous mutation in the SAM domain of p63 underlies Rapp-Hodgkin ectodermal dysplasia.
Kantaputra PN; Hamada T; Kumchai T; McGrath JA
J Dent Res; 2003 Jun; 82(6):433-7. PubMed ID: 12766194
[TBL] [Abstract][Full Text] [Related]
13. The p63 gene in EEC and other syndromes.
Brunner HG; Hamel BC; Van Bokhoven H
J Med Genet; 2002 Jun; 39(6):377-81. PubMed ID: 12070241
[TBL] [Abstract][Full Text] [Related]
14. A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes.
Rinne T; Clements SE; Lamme E; Duijf PH; Bolat E; Meijer R; Scheffer H; Rosser E; Tan TY; McGrath JA; Schalkwijk J; Brunner HG; Zhou H; van Bokhoven H
Hum Mol Genet; 2008 Jul; 17(13):1968-77. PubMed ID: 18364388
[TBL] [Abstract][Full Text] [Related]
15. Two novel TP63 mutations associated with the ankyloblepharon, ectodermal defects, and cleft lip and palate syndrome: a skin fragility phenotype.
Payne AS; Yan AC; Ilyas E; Li W; Seykora JT; Young TL; Pawel BR; Honig PJ; Camacho J; Imaizumi S; Heymann WR; Schnur RE
Arch Dermatol; 2005 Dec; 141(12):1567-73. PubMed ID: 16365259
[TBL] [Abstract][Full Text] [Related]
16. NMR structure of the p63 SAM domain and dynamical properties of G534V and T537P pathological mutants, identified in the AEC syndrome.
Cicero DO; Falconi M; Candi E; Mele S; Cadot B; Di Venere A; Rufini S; Melino G; Desideri A
Cell Biochem Biophys; 2006; 44(3):475-89. PubMed ID: 16679535
[TBL] [Abstract][Full Text] [Related]
17. Differential PERP regulation by TP63 mutants provides insight into AEC pathogenesis.
Beaudry VG; Pathak N; Koster MI; Attardi LD
Am J Med Genet A; 2009 Sep; 149A(9):1952-7. PubMed ID: 19353588
[TBL] [Abstract][Full Text] [Related]
18. P63 gene mutations and human developmental syndromes.
Brunner HG; Hamel BC; Bokhoven Hv Hv
Am J Med Genet; 2002 Oct; 112(3):284-90. PubMed ID: 12357472
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of p63α SAM domain mutants involved in AEC syndrome.
Sathyamurthy A; Freund SM; Johnson CM; Allen MD; Bycroft M
FEBS J; 2011 Aug; 278(15):2680-8. PubMed ID: 21615690
[TBL] [Abstract][Full Text] [Related]
20. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.
Serber Z; Lai HC; Yang A; Ou HD; Sigal MS; Kelly AE; Darimont BD; Duijf PH; Van Bokhoven H; McKeon F; Dötsch V
Mol Cell Biol; 2002 Dec; 22(24):8601-11. PubMed ID: 12446779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
